Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2-6 With Cystic Fibrosis. Dagan A, Hadhud M, Efrati O, Cahanovitc SS, et al. Pediatr Pulmonol 2026;61:e71523.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dagan A, Hadhud M, Efrati O, Cahanovitc SS, et al. Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2-6 With Cystic Fibrosis. Pediatr Pulmonol 2026;61:e71523.
PMID: 41704044